Ventas Inc., US92276F1003

Ventas stock gains on a moderate buy consensus

Published on 08/25/2026 at 15:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ventas stock has 15 buy ratings and three holds from 18 analysts, with a $98.00 average target and a $93.47 opening price on August 25, 2026.

Aquarellmalerei einer Stadtskyline mit modernem Gesundheitscampus und Park im Vordergrund
Ventas Inc. (US92276F1003) besitzt Gesundheitsimmobilien in US-Städten, Aquarell zeigt Skyline mit Gesundheitscampus bei Sonnenuntergang, Illustration mit AI erstellt.

Ventas Inc. (US92276F1003) stock opened at $93.47 on August 25, 2026, and analysts now show a $98.00 average 12-month target with 15 buy ratings and three holds across 18 analysts.

Analysts lean constructive

The latest market snapshot gives Ventas a $47.94 billion market cap and a 52-week range of $66.38 to $101.60, while the shares trade on a 50-day average of $91.56 and a 200-day average of $87.26.

The rating mix points to a market that still sees room for the healthcare REIT, even after the stock moved above its shorter-term averages.

Quarterly numbers matter

Ventas reported $0.97 in diluted EPS for the quarter ended July 29, 2026, beating the $0.96 consensus by $0.01. Revenue came in at $1.73 billion, above the $1.68 billion estimate, and the company said quarterly revenue rose 21.7% from the same quarter a year earlier.

That same quarter also produced a 4.08% net margin and a 1.99% return on equity, giving investors a clearer read on how much of the top-line strength is still filtering through to profit.

Institutional activity adds another layer: one filing showed 62,228 shares bought for about $5.53 million, and another reported 43,220 shares acquired for about $3.84 million.

Peer context

For healthcare REIT investors, the key comparison is not just the consensus target but the spread between the $93.47 opening price and the $98.00 average target. The gap is modest, yet it comes after a quarter with $1.73 billion in revenue and EPS that edged past expectations.

What Ventas owns

Ventas owns and manages healthcare-focused real estate, including senior housing communities, skilled nursing facilities, medical office buildings, and life science properties. That mix keeps the company tied to long-term leases and asset management rather than a single property type.

Price and venue

NYSE: VTR traded at $93.47 on August 25, 2026, with a market cap of $47.94 billion. The shares sit below the 52-week high of $101.60 and above the 52-week low of $66.38.

Company

Company: Ventas Inc.

ISIN: US92276F1003

Ticker: VTR

Exchange: NYSE

Price (as of August 25, 2026): $93.47 USD

Market cap: $47.94 billion

Sector / Industry: Real Estate / Healthcare REITs

Index membership: S&P 500

Next earnings date: November 4, 2026

More on Ventas stock

Ventas runs a healthcare real estate portfolio that spans senior housing, skilled nursing, medical office, and life science assets. The group generates cash flow mainly through long-term leases and property management tied to the healthcare system.

Disclaimer...

en | US92276F1003 | VENTAS INC. | boerse | 69999457 | bgmi